Alla Rudinskaya is a Rheumatology/Immunology physician affiliated with Danbury Hospital. OpenAlex indexes 19 publications with 319 citations (h-index 8).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
41 Germantown Rd
Danbury, CT 068104087
Telephone
203-207-3320Registry record last updated 8 Jul 2007.
Industry payments
7 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20252 payments
- UCB, Inc.Program year20251 payment
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
74.4%TNF inhibitor72.8%Certolizumab pegol100%Cimzia (2 Pack)0%Humira(Cf) Pen0%Part D + Part B<11 patientsFolate Analog Metabolic Inhibitor0.9%Methotrexate78%Methotrexate Sodium12%Rasuvo10%Part D<11 patients+ 3 more classes in this area
Musculoskeletal
22.6%RANK Ligand Inhibitor22.1%Denosumab100%Part B, office-administered≥63 patientsXanthine oxidase inhibitor0.3%Allopurinol100%Part D≥18 patients+ 2 more classes in this area
Metabolism & gastrointestinal
1%Corticosteroid0.9%Prednisone100%Part D≥66 patientsAntidiarrheal microorganisms0.1%Folic Acid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- STATIN INDUCED NECROTIZING AUTOIMMUNE MYOPATHY WITHOUT CONCURRENT STATIN USE: YET ANOTHER SEQUELA OF COVID-19?
Journal of the American College of Cardiology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Daniel Labow, MD
Danbury Hospital
Vincent Rella, MD
Danbury Hospital
Paul Iannini, MD
Danbury Hospital
Steven Brandwein, MD
Danbury Hospital
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”